Search - tctmd.com

Displaying 321 - 340 of 345

Sort: Relevancy | Date

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Caitlin E. Cox

April 19, 2013

News Daily News

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

Yael L. Maxwell

March 09, 2013

News Daily News

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Caitlin E. Cox

March 09, 2013

News Daily News

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Yael L. Maxwell

December 13, 2012

News Daily News

Longer Hospital Stay Linked with Less Evidence-Based Care in NSTEMI

Yael L. Maxwell

December 05, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

PCI Rates for Acute MI Lower in States with Public Reporting

Yael L. Maxwell

October 10, 2012

News Daily News

Danish Study Looks at Impact of Socioeconomic Status on Primary PCI Outcomes

Caitlin E. Cox

October 09, 2012

News Conference News ESC 2012

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

Caitlin E. Cox

August 27, 2012

News Daily News

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

July 03, 2012

News Daily News

Several Factors Behind False-Positive STEMI Activations

Yael L. Maxwell

May 09, 2012

News Daily News

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Yael L. Maxwell

February 20, 2012

News Daily News

Similar Mortality Rates Seen in Men and Women with NSTE ACS

L.A. McKeown

January 26, 2012

News Daily News

STEMI Patients Not Achieving Recommended Transfer Times for PCI

L.A. McKeown

December 05, 2011

News Conference News

MI FREEE: Free Post-MI Drugs Reduce Events, Costs

November 15, 2011

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Jason Kahn

September 26, 2011

News Daily News

Door-to-Balloon Times Improve Drastically Over 6-Year Period

Jason Kahn

August 22, 2011

News Daily News

Thrombus Burden May Explain Disadvantage of Facilitated PCI

May 04, 2011

Advertisement

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Longer Hospital Stay Linked with Less Evidence-Based Care in NSTEMI

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

PCI Rates for Acute MI Lower in States with Public Reporting

Danish Study Looks at Impact of Socioeconomic Status on Primary PCI Outcomes

Low-Dose Rivaroxaban Curbs Thrombotic Events in STEMI Patients

More Than Half of Readmissions Within 30 Days of Acute MI Unrelated to Index Event

Meta-analysis: Early Invasive Strategy Best for Diabetic Patients with NSTE ACS

Several Factors Behind False-Positive STEMI Activations

Younger Women with AMI Less Likely to Present with Chest Pain Than Men

Similar Mortality Rates Seen in Men and Women with NSTE ACS

STEMI Patients Not Achieving Recommended Transfer Times for PCI

MI FREEE: Free Post-MI Drugs Reduce Events, Costs

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Door-to-Balloon Times Improve Drastically Over 6-Year Period

Thrombus Burden May Explain Disadvantage of Facilitated PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content